In the RPV/FTC/TDF arm , isolates from @/@ subjects ( @ % ) developed nonnucleoside reverse transcriptase inhibitor ( NNRTI ) and/or nucleoside reverse transcriptase inhibitor ( NRTI ) resistance mutations , and @/@ isolates had both NNRTI and NRTI resistance mutations .